Super El Niño forecasts have strengthened, with forecasters warning of increased risks of extreme weather this fall and ...
FDA’s PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell ...
The number of practitioners has dramatically risen in Britain, but it's no longer as lucrative a field as you might expect ...
FDA's PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIR ...
Few discoveries in a garden carry the quiet electricity of this one. Digging through a neglected corner of a backyard, a ...